FDA Inspection
Stembanc Holdings IncStembanc Holdings Inc – FDA Inspection, Sep 23, 2021
Record Details
This FDA Inspection record concerns Stembanc Holdings Inc, with an inspection on September 23, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Stembanc Holdings Inc
- Inspection Date
- September 23, 2021
- Product Type
- Biologics
View Company Profile
ID · e4d99e70-7e15-4f78-b8fa-b958165e98dd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1154700
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Stembanc Holdings Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2024 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Stembanc Holdings Inc
- FDA Inspection 1242236 - 2024-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.